COMP <GO>
APYX vs LUNG // FREE CASH FLOW YIELD
Apyx Medical Corporation (NASDAQ) VS. Pulmonx Corporation (NASDAQ) • 15-METRIC TALLY: APYX 6
— LUNG 4
▲ FREE CASH FLOW YIELD LEADER: APYX
LAST: $2.60 (-3.35%) • MKT CAP: $113.3M
fcf-yield
-8.04%
LAST: $3.01 (-5.05%) • MKT CAP: $135.9M
fcf-yield
-24.15%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (APYX VS. LUNG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | APYX | LUNG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.50% | 74.20% | -11.70 | LUNG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -28.90% | -35.00% | +6.10 | APYX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | -8.04% | -24.15% | +16.11 | APYX | /fcf-yield <GO> |
| Operating Margin | -12.20% | -59.30% | +47.10 | APYX | /operating-margins <GO> |
| Net Profit Margin | -21.20% | -59.70% | +38.50 | APYX | /net-margins <GO> |
| Revenue Growth (YoY) | 9.90% | 8.00% | +1.90 | APYX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.75 | 0.20 | +0.55 | APYX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 6/9 | -1.00 | LUNG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.1 | 79.1 | -29.95 | LUNG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $113.3M | $135.9M | -$22.6M | LUNG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | APYX REV | LUNG REV | APYX GROSS % | LUNG GROSS % | APYX FCF | LUNG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $52.8M | $90.5M | 62.5% | 74.2% | -$9.1M | -$32.8M |
| FY 2024 | $48.1M | $83.8M | 61.0% | 74.0% | -$18.8M | -$33.0M |
| FY 2023 | $52.3M | $68.7M | — | — | -$5.2M | -$37.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
APYX // BETA —
LUNG // BETA —